将产前唐氏综合征母血清筛查从孕中期移至孕早期对脊柱裂筛查的影响
该研究回顾性分析了2009年至2011年742例产前诊断的脊柱裂病例,按母血清标志物筛查方式分为孕中期筛查组、孕早期筛查组和未筛查组。结果显示孕早期筛查组诊断孕周中位数为22+1周,孕中期筛查组为22周,未筛查组为21+4周(P<0.005);孕中期筛查组在14-20周诊断的比例为34.7%,孕早期筛查组为8.5%(P<0.001)。结论认为母血清甲胎蛋白筛查的缺失对脊柱裂诊断孕周有实质性影响,导致20周前发现的病例减少25%。
要点
- 孕早期筛查组14-20周诊断脊柱裂的比例为8.5%,低于孕中期筛查组的34.7%(P<0.001)。
- 2009年至2011年,14-20周诊断脊柱裂的比例从38.8%下降至13.3%(P<0.001)。
- 母血清甲胎蛋白筛查的缺失导致20周前发现的脊柱裂病例减少25%。
核心结论
- 母血清甲胎蛋白筛查的缺失对脊柱裂诊断孕周有实质性影响,导致20周前发现的脊柱裂病例减少25%。
研究设计与样本
- 回顾性分析2009年(仅孕中期筛查)、2010年(过渡期)和2011年(多数为孕早期筛查)三年内产前诊断的742例脊柱裂病例。
- 病例根据母血清标志物筛查方式分为孕中期筛查组、孕早期筛查组和未筛查组。
主要发现
- 三组诊断脊柱裂的孕周中位数分别为22周[18+6-23]、22+1周[21+3-23]和21+4周[14+1-23](P<0.005)。
- 孕中期筛查组在14-20周诊断的比例为34.7%,孕早期筛查组为8.5%(P<0.001)。
- 14-20周诊断脊柱裂的比例从2009年的38.8%下降至2011年的13.3%(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Shifting screening for trisomy 21 to the first trimester has resulted in the loss of maternal serum alpha-fetoprotein screening for spina bifida. The aim of this study was to study the impact on open spina bifida prenatal screening. STUDY DESIGN: We reviewed prenatally diagnosed cases of spina bifida over three years: 2009 (only second-trimester screening, MSM2T), 2010 (transient period) and 2011 (majority first-trimester screening, MSM1T). Cases were assigned to three groups based on maternal serum markers (MSM2T, MSM1T and 'not performed'). Gestational age at diagnosis of spina bifida was compared between these three groups and between the years 2009 and 2011. RESULTS: Median gestational ages at diagnosis of the 742 spina bifida cases between the three groups were 22 weeks [18+6 -23], 22+1 weeks [21+3 -23] and 21+4 weeks [14+1 -23], respectively (P < 0.005). The diagnosis was made at 14-20 weeks in 34.7% for MSM2T group versus 8.5% for MSM1T (P < 0.001). Spina bifida diagnosis at 14-20 weeks declined from 38.8% in 2009 to 13.3% in 2011 (P < 0.001). CONCLUSION: Loss of maternal serum alpha-fetoprotein had a tangible effect on the gestational age at diagnosis of spina bifida and resulted in a decrease of 25% of cases of spina bifida detected before 20 weeks. © 2017 John Wiley & Sons, Ltd.
引用
- Spaggiari E, Dreux S, Stirnemann JJ, et al. Impact on spina bifida screening of shifting prenatal Down syndrome maternal serum screening from the second trimester to the first. Prenat Diagn. 2017. PMID: 28453864. doi:10.1002/pd.5064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。